Sfoglia per AUTORE
CASALE F
Collezione AOU Novara

  

Items : 5

The role of peripheral immunity in ALS: a population-based study. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2023 Sep;10(9):1623-1632. doi: 10.1002/acn3.51853. Epub 2023 Jul 22.

2023
AOU Novara
AOU Città della Salute di Torino

Calvo A; Mazzini L; Casale F; Fuda G; Salamone P; Canosa A; Vasta R; Palumbo F; Bombaci A; Solero L; Daviddi M; Matteoni E; Cugnasco P; De Marchi F; Manera U; Grassano M; Moglia C; Chiò A;

Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients. in Amyotrophic lateral sclerosis & frontotemporal degeneration / Amyotroph Lateral Scler Frontotemporal Degener. 2023 May;24(3-4):343-346. doi: 10.1080/21678421.2022

2023
AOU Città della Salute di Torino
AOU Novara

Manera U; Chiò A; Calvo A; Moglia C; De Marchi F; Mazzini L; Salamone P; De Mattei F; Casale F; Di Pede F; Matteoni E; Cabras S; Grassano M; Canosa A; Vasta R; Callegaro S;

Systematic evaluation of genetic mutations in ALS: a population-based study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Jul 27;93(11):1190-3. doi: 10.1136/jnnp-2022-328931.

2022
AOU Città della Salute di Torino
AOU Novara

Chiò A; Traynor B; Karra R; Chia R; Dalgard C; D'Alfonso S; Corrado L; Mazzini L; Canosa A; Manera U; Vasta R; Casale F; Barberis M; Brunetti M; Sbaiz L; Moglia C; Grassano M; Calvo A;

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. in JAMA neurology / JAMA Neurol. 2021 Oct 1;78(10):1236-1248. doi: 10.1001/jamaneurol.2021.2598.

2021
ASL Cuneo 2
AOU Città della Salute di Torino
AOU Novara

Zollino M; Zucchi E; Volanti P; Vacchiano V; Vita G; Vasta R; Trojsi F; Tranquilli S; Tremolizzo L; Tedeschi G; Ticca A; Torriello A; Spataro R; Tanel R; Simonini C; Sbaiz L; Sideri R; Simone I; Santarelli M; Salvi F; Salivetto M; Riva N; Russo M; Sabatelli M; Salamone P; Riolo G; Ricci C; Quattrini A; Pozzi S; et alii...

G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial). in BMJ open / BMJ Open. 2020 Mar 24;10(3):e034049. doi: 10.1136/bmjopen-2019-034049.

2020
AOU Città della Salute di Torino
AOU Novara

Calvo A; Moglia C; Simone IL; Mandrioli J; La Bella V; Mazzini L; Caponnetto C; Lunetta C; Marrali G; Casale F; Fuda G; Salamone P; Tarella C; Chio A;